USP9X and glioblastoma: Pharmacological inhibition of HDAC6 and USP9X using ACY738, a blood‐brain barrier‐permeable HDAC6 inhibitor, and WP1130 also suppressed GBM cell growth and induced apoptosis (Figure5A–F) at concentrations that did not affect normal cell viability (Figure S6, Supporting Information).